BRAF-mutations in non-small cell lung cancer

被引:63
|
作者
Brustugun, Odd Terje [1 ,2 ]
Khattak, Asma Malik [3 ]
Tromborg, Anette Kjoshagen [3 ]
Beigi, Marzieh [3 ]
Beiske, Klaus [3 ]
Lund-Iversen, Marius [3 ]
Helland, Aslaug [1 ,2 ]
机构
[1] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Oncol, N-0310 Oslo, Norway
[2] Univ Oslo, Inst Clin Med, Oslo, Norway
[3] Norwegian Radium Hosp, Oslo Univ Hosp, Dept Pathol, N-0310 Oslo, Norway
关键词
EGFR-mutation; BRAF-mutation; Genetic testing; Lung cancer; Tyrosine kinase inhibitors; ADENOCARCINOMAS; FEATURES; PATIENT;
D O I
10.1016/j.lungcan.2014.01.023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Targeted therapies in non-small cell lung cancer (NSCLC) now also include inhibitors against mutated BRAF. We present clinicopathological characteristics of nearly one thousand unselected NSCLC patients tested for the targetable V600E/K BRAF-mutation. Material and methods: NSCLC routinely tested for EGFR-mutations at Oslo University Hospital in the period February 2011-July 2013 were tested for V600E/K BRAF-mutations using a PCR-based method. Results: We found a BRAF-mutation frequency of 1.7% in the total cohort of 979 patients, and 23% among 646 adenocarcinomas. One of the BRAF-positive samples was also KRAS-mutated, and one had an ALK-translocation. None of 231 squamous cell carcinomas were BRAF-mutated. The proportion of never-smokers among BRAF-positives was high (29%). Conclusion: BRAF-mutation analysis should be part of the subtyping of non-squamous NSCLC. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:36 / 38
页数:3
相关论文
共 50 条
  • [1] Non-small cell Lung Cancer (NSCLC) with BRAF-Mutations - A single center Observational Study
    Lips, C.
    Rafflenbeul, G.
    Blum, T. G.
    Kollmeier, J.
    Misch, D.
    Schaefer, M.
    Stephan-Falkenau, S.
    Streubel, A.
    Thiel, S.
    Mairinger, T.
    Bauer, T. T.
    PNEUMOLOGIE, 2020, 74 : S134 - S135
  • [2] BRAF mutations in non-small cell lung cancer
    Luk, Peter P.
    Yu, Bing
    Ng, Chiu Chin
    Mercorella, Belinda
    Selinger, Christina
    Lum, Trina
    Kao, Steven
    O'Toole, Sandra A.
    Cooper, Wendy A.
    TRANSLATIONAL LUNG CANCER RESEARCH, 2015, 4 (02) : 142 - 148
  • [3] Targeting BRAF mutations in non-small cell lung cancer
    O'Leary, Connor Gerard
    Andelkovic, Vladamir
    Ladwa, Rahul
    Pavlakis, Nick
    Zhou, Caicun
    Hirsch, Fred
    Richard, Derek
    O'Byrne, Kenneth
    TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (06) : 1119 - 1124
  • [4] BRAF MUTATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER: A POOLED ANALYSIS
    Huang, Z. -M.
    An, S. -J.
    Huang, L.
    Wu, Y. -L.
    ANNALS OF ONCOLOGY, 2012, 23 : 48 - 48
  • [5] BRAF MUTATIONS IN PATIENTS WITH NON-SMALL CELL LUNG CANCER: A POOLED ANALYSIS
    Huang, Zhi-min
    An, She J.
    Wu, Yi-long
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S458 - S458
  • [6] BRAF Inhibitors in Non-Small Cell Lung Cancer
    Sforza, Vincenzo
    Palumbo, Giuliano
    Cascetta, Priscilla
    Carillio, Guido
    Manzo, Anna
    Montanino, Agnese
    Sandomenico, Claudia
    Costanzo, Raffaele
    Esposito, Giovanna
    Laudato, Francesca
    Damiano, Simona
    Forte, Cira Antonietta
    Frosini, Giulia
    Farese, Stefano
    Piccirillo, Maria Carmela
    Pascarella, Giacomo
    Normanno, Nicola
    Morabito, Alessandro
    CANCERS, 2022, 14 (19)
  • [7] Clinical Significance of BRAF Gene Mutations in Patients with Non-small Cell Lung Cancer
    Kobayashi, Masashi
    Sonobe, Makoto
    Takahashi, Tsuyoshi
    Yoshizawa, Akihiko
    Ishikawa, Masashi
    Kikuchi, Ryutaro
    Okubo, Kenichi
    Huang, Cheng-Long
    Date, Hiroshi
    ANTICANCER RESEARCH, 2011, 31 (12) : 4619 - 4623
  • [8] BRAF Mutations in Non-Small-Cell Lung Cancer
    Smit, Egbert
    JOURNAL OF THORACIC ONCOLOGY, 2014, 9 (11) : 1594 - 1595
  • [9] Clinical, Pathologic, and Biologic Features Associated with BRAF Mutations in Non-Small Cell Lung Cancer
    Cardarella, Stephanie
    Ogino, Atsuko
    Nishino, Mizuki
    Butaney, Mohit
    Shen, Jeanne
    Lydon, Christine
    Yeap, Beow Y.
    Sholl, Lynette M.
    Johnson, Bruce E.
    Jaenne, Pasi A.
    CLINICAL CANCER RESEARCH, 2013, 19 (16) : 4532 - 4540
  • [10] BRAF mutations in non-small cell lung cancer: has finally Janus opened the door?
    Caparica, Rafael
    de Castro, Gilberto, Jr.
    Gil-Bazo, Ignacio
    Caglevic, Christian
    Calogero, Raffaele
    Giallombardo, Marco
    Santos, Edgardo S.
    Raez, Luis E.
    Rolfo, Christian
    CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY, 2016, 101 : 32 - 39